- Trials with a EudraCT protocol (144)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
144 result(s) found for: Urethra.
Displaying page 1 of 8.
EudraCT Number: 2018-003532-71 | Sponsor Protocol Number: MC/Ph.III-2019 | Start Date*: 2019-10-29 | |||||||||||
Sponsor Name:MukoCell GmbH | |||||||||||||
Full Title: Efficacy and safety of a tissue-engineered oral mucosa (MukoCell®) vs. native oral mucosa graft urethroplasty in male patients with urethral stricture | |||||||||||||
Medical condition: Urethral stricture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000514-33 | Sponsor Protocol Number: OZBS62.20366 | Start Date*: 2022-10-10 | |||||||||||||||||||||
Sponsor Name:Erasmus MC | |||||||||||||||||||||||
Full Title: CHemotherapy And Sequential ImmunoTherapy for locally advanced urothelial cancer: the CHASIT study | |||||||||||||||||||||||
Medical condition: Urothelial cancer of the bladder, upper urinary tract or urethra. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001527-39 | Sponsor Protocol Number: SGN22E-002 | Start Date*: 2021-02-16 | ||||||||||||||||||||||||||
Sponsor Name:Seagen Inc. | ||||||||||||||||||||||||||||
Full Title: A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer | ||||||||||||||||||||||||||||
Medical condition: Urothelial cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Trial now transitioned) IT (Restarted) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001841-34 | Sponsor Protocol Number: PLUTO2011 | Start Date*: 2012-01-12 | |||||||||||||||||||||
Sponsor Name:NHS Greater Glasgow Health Board [...] | |||||||||||||||||||||||
Full Title: A Randomised Phase II study investigating pazopanib vs weekly paclitaxel in relapsed or progressive Transitional Cell Carcinoma (TCC) of the urothelium. | |||||||||||||||||||||||
Medical condition: Relapsed or progressive Transitional Cell Carcinoma (TCC) of the urothelium | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-001167-23 | Sponsor Protocol Number: IMMU-132-06 | Start Date*: 2019-03-20 | ||||||||||||||||||||||||||
Sponsor Name:Immunomedics, Inc. | ||||||||||||||||||||||||||||
Full Title: A Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based Immunotherapy | ||||||||||||||||||||||||||||
Medical condition: Histologically documented locally advanced (tumor [T] 4b, any node [N]; or any T, N 2-3) or metastatic (M1, Stage IV) urothelial or non-urothelial carcinoma of the urinary tract predominant | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Ongoing) DE (Trial now transitioned) ES (Ongoing) GR (Trial now transitioned) IT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002417-35 | Sponsor Protocol Number: NUCOGI-VINGEM | Start Date*: 2013-09-10 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Department of Oncology, Karolinska University Hospital | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A multicenter, randomized phase II trial of vinflunine/gemcitabine versus carboplatin /gemcitabine as first line treatment in patients with metastatic urothelial carcinoma unfit for cisplatin based... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: Locally advanced or Metastatic urothelial carcinoma | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Completed) DK (Completed) FI (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-003479-78 | Sponsor Protocol Number: SGN22E-001 | Start Date*: 2018-08-29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Seattle Genetics Inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoin... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with locally advanced or metastatic urothelial cancer. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) ES (Completed) NL (Completed) IT (Restarted) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003625-17 | Sponsor Protocol Number: CA209-275 | Start Date*: 2015-01-27 | |||||||||||||||||||||||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||||||||||||||||||||||
Full Title: A phase II single arm clinical trial of nivolumab (BMS-936558) in subjects with metastatic or unresectable urothelial cancer who have progressed or recurred following treatment with a platinum agen... | |||||||||||||||||||||||||||||||||
Medical condition: metastatic or unresectable urothelial cancer | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Completed) ES (Ongoing) BE (Completed) SE (Completed) CZ (Completed) FI (Completed) PL (Completed) IT (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000049-30 | Sponsor Protocol Number: RITE-2 | Start Date*: 2017-07-26 |
Sponsor Name:Medical Enterprises Europe B.V | ||
Full Title: A multicenter, single-arm study evaluating the efficacy of Synergo radiofrequency-induced thermochemotherapy effect (RITE) with Mitomycin C( Synergo + MMC) in non-muscle invasive bladder cancer (NM... | ||
Medical condition: Non-Muscle-Invasive Bladder Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004858-33 | Sponsor Protocol Number: Version 2.0 (03Nov2010) | Start Date*: 2009-01-09 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: Open label pilot study to treat women with chronic urinary retention or voiding dysfunction due to a primary disorder of sphincter relaxation (Fowler’s syndrome) with outpatient urethral sphincter ... | |||||||||||||
Medical condition: Primary abnormality of the urethral sphincter or Fowlers Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002964-29 | Sponsor Protocol Number: IMMU-132-13 | Start Date*: 2021-10-12 | ||||||||||||||||||||||||||
Sponsor Name:Gilead Sciences Inc | ||||||||||||||||||||||||||||
Full Title: A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer | ||||||||||||||||||||||||||||
Medical condition: Metastatic or Locally Advanced Unresectable Urothelial Cancer | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SE (Ongoing) PT (Completed) BE (Ongoing) AT (Ongoing) IT (Ongoing) IE (Ongoing) HU (Completed) BG (Ongoing) CZ (Completed) HR (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000907-27 | Sponsor Protocol Number: D2782C00010 | Start Date*: 2008-10-24 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Phase II, Single Arm, Single Agent, Multicentre, Adaptive 2-Stage Study to Evaluate the Efficacy, Safety and Pharmacokinetics of AZD4877 Administered Weekly in Patients with Recurrent Advanced Ur... | ||
Medical condition: Stage IV urothelial Cancer Cáncer de urotelio estadío 4 | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: ES (Completed) DE (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024649-61 | Sponsor Protocol Number: POXY11 | Start Date*: 2011-04-05 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Centre | |||||||||||||
Full Title: Pilot study: performance of the Progensa PCA3 test in post-oxytocin urine specimens | |||||||||||||
Medical condition: Healthy volunteer trial: intended indication for product is to mobilize prostate cells in urethra for PCA3 test. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002206-20 | Sponsor Protocol Number: MK-3475-052 | Start Date*: 2014-12-22 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase II Clinical Trial of Pembrolizumab (MK-3475) in Subjects with Advanced/Unresectable or Metastatic Urothelial Cancer | |||||||||||||
Medical condition: advanced/unresectable (inoperable) or metastatic urothelial cancer of the renal pelvis, ureter, bladder, or urethra. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DK (Completed) IT (Completed) IE (Completed) GB (GB - no longer in EU/EEA) HU (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020722-18 | Sponsor Protocol Number: DESMOPRESINA | Start Date*: 2009-04-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE POLICLINICO CONSORZIALE | |||||||||||||
Full Title: 1-DEAMINO 8-D-ARGININA VASOPRESSIN IN PERCUTANEOUS ULTRASOUND-GUIDED RENAL BIOPSY: A RANDOMIZED CONTROLLED TRIAL | |||||||||||||
Medical condition: Patients undergoing percutaneous ultrasound-guided biopsy of native kidney and at high risk of bleeding | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003337-24 | Sponsor Protocol Number: 180 | Start Date*: 2013-06-26 | ||||||||||||||||
Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA | ||||||||||||||||||
Full Title: Diagnostic imaging in prostate cancer (as in tumours with accelerated menbrane turn-over)by F-18 Fluoro-metil-choline PET/CT | ||||||||||||||||||
Medical condition: patients with prostate cancer istologically proven | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024023-25 | Sponsor Protocol Number: Nefrovid2010 | Start Date*: 2011-09-22 | |||||||||||
Sponsor Name:Lorenzo Victor, PhD | |||||||||||||
Full Title: An open label, parallel groups, phase III, clinical trial to assess the antiproteinuric effects of the vitamin D derivates in patients with chronic kidney disease and vitamin D insufficiency. | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002470-23 | Sponsor Protocol Number: 2011-002470-23 | Start Date*: 2011-06-09 | |||||||||||||||||||||
Sponsor Name:ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED | |||||||||||||||||||||||
Full Title: Evaluation of diagnosic accuracy of 18F-choline PET/CT in examination of patients qith prostate cancer, in relation to PSA value and its derivatives. | |||||||||||||||||||||||
Medical condition: Patients with prostate cancer histologically proved | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005552-41 | Sponsor Protocol Number: ALADIN | Start Date*: 2006-02-20 | |||||||||||
Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI | |||||||||||||
Full Title: Effect of long-acting somatostatin on disease progression in nephropathy due to autosomal dominant polycystic disease a long-term three year follow-up study | |||||||||||||
Medical condition: Autosomal Dominant Polycystic Kidney Disease ADPKD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003885-40 | Sponsor Protocol Number: ACEARB 1 | Start Date*: 2005-10-18 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PROVINCIALE DI LECCO | |||||||||||||
Full Title: ACE-inhibitors and Angiotensin two receptor antagonists in IgA nephropathy with mild proteinuria | |||||||||||||
Medical condition: The primary aim of the study consists in testing the hypothesis that blockade of the RAS may decrease the risk of developing adverse effects in patients with benign IgAN.Such blockade would first a... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.